Drs Ketter and Rasgon have received research grant support and honoraria from GlaxoSmithKline and Abbott Laboratories, but these companies did not provide support for the work described in this manuscript. Ms Glenn is an employee of ChronoRecord Association, Inc., ChronoRecord software was provided by ChronoRecord Association, Inc.
Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report
Article first published online: 21 SEP 2004
Volume 6, Issue 5, pages 435–439, October 2004
How to Cite
Becker, O., Rasgon, N., Marsh, W., Glenn, T. and Ketter, T. (2004), Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report. Bipolar Disorders, 6: 435–439. doi: 10.1111/j.1399-5618.2004.00146.x
- Issue published online: 21 SEP 2004
- Article first published online: 21 SEP 2004
- Received 10 September 2003, revised and accepted for publication 15 June 2004
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.